← FDA DRUG APPROVALS

FDA NDA · NDA018548

THALLOUS CHLORIDE TL 201

Sponsor: BRACCO

APPLICATION
NDA018548
TYPE
NDA
ORIGINAL APPROVAL
1982-12-30
LATEST ACTION
2000-12-05
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

THALLOUS CHLORIDE TL 201Discontinued
THALLOUS CHLORIDE TL-201 1mCi/ML · INJECTABLE · INJECTION

Approval history

2000-12-05Manufacturing (CMC) · Supplement 7 · standardAP
2000-07-21Manufacturing (CMC) · Supplement 6 · standardAP
1988-03-28Labeling · Supplement 5AP
1985-06-26Manufacturing (CMC) · Supplement 3 · standardAP
1984-11-08Manufacturing (CMC) · Supplement 1 · standardAP
1984-05-22Manufacturing (CMC) · Supplement 2 · standardAP
1982-12-30Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →